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Available online 8 June 2016Primary and secondary cardiac tumors are a very rare entity, but secondary heart tumors are more common.
Cardiac metastases occur in 10% all cancer patients. Hepatocellular carcinoma (HCC) is a very aggressive
tumor. Intra-cardiac involvement with HCC rarely develops in a patientwith HCC, and it has very poor prognosis.
The clinical course of these patients may be complicated by many fatal cardiovascular complications. After the
diagnosis of the heart involvement, median survival range is 1–4months. Early diagnosis of cardiac involvement
is very important and its easyway is performing echocardiography.We describe here a rare case of a 65-year-old
man with HCC that invaded the heart in 3 months.
© 2016 The Society of Cardiovascular Academy. Production and hosting by Elsevier B.V. All rights reserved. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Cardiac tumors are very rare entity.1 In contrast to primary malig-
nant cardiac tumors, metastatic involvement of the heart is relatively
common. Malignant melanomas are likely to metastasize to the heart.
Other solid tumors commonly associated with cardiac involvement
include lung cancer, breast cancer, soft tissue sarcomas, renal carcino-
ma, esophageal cancer, hepatocellular carcinoma, and thyroid cancer.2
Cardiac involvement with other tumors may arise from hematogenous
metastases, direct invasion from the mediastinum, or tumor growth
into the vena cava and extension into the right atrium (RA).3 Primary
hepatocellular carcinoma (HCC) is the ﬁfth most common cancer
worldwide and the third-leading cause of cancer-related death.4,5
HCC metastases tend to spread through intrahepatic blood vessels,
lymphatics, or direct inﬁltration. HCCs frequently invade the vascular
system at points such as the portal and hepatic veins. Intra-cardiac in-
volvement of HCC rarely develops and themainmechanism ofmetasta-
sis into the cardiac cavity is direct extension the tumor to the heart via
hepatic vein and vena cava inferior.2 The results of autopsy studies indi-
cate a 2.7–4.1% incidence of atrial metastases of HCC.6 A correct diagno-
sis is important in the clinical setting since cardiacmetastases are able to
induce sudden cardiac arrest.y, Medifema Hospital, Mustafa
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A 65-year-old man with a history of hepatocellular carcinoma for
1 year presented to the cardiology clinic for dyspnea and new onset
bilateral lower extremity edema rapidly progressing over 2 weeks.
The diagnosis was made by hepatic biopsy and he was followed
by medical oncology for 1 year with the treatment of sorafenib
(multikinase inhibitor).
On physical examination, the heart rhythm was sinus, 2/6 systolic
murmur in cardiac auscultation. There was pitting edema in lower
extremities bilaterally and approximately 10 cm palpable mass at
right upper quadrant of the abdomen.
2-D transthoracic echocardiography demonstrated a large mass in
the right atrium extending to the tricuspid valvewithout signiﬁcant ob-
struction (Fig. 1). Thoracic and upper abdominal computer tomography
(CT) showed expansile liver mass with the extension of the tumor into
the right atrium via invasion of the inferior vena cava (Fig. 2).
Compared with the previous CT and echocardiography images made
3months ago, the hepaticmass of the liverwas smaller and therewas no
VCI or intra-cardiac extension of HCC (Fig. 2). During this 3 months the
liver mass got enlarged and invaded inferior vena cava thus reached
the RA.
The patient was followed up conservatively because of the end-
staged metastatic HCC and high mortality risk of the heart surgery. He
died in 76 days after the diagnosis of intra-cardiac tumor because of
liver andmulti-organ failure.Wedid not identify left ventricular systolic
failure during this follow-up time.sevier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND
Fig. 1. 2-D and color Doppler transthoracic echocardiography in apical four chamber view.
Echocardiography demonstrated a huge mobile mass that ﬁlls all the right atrium space
(arrow). The mass was very mobile and protruding into the RV. LV, left ventricle; LA, left
atrium; RV, right ventricle.
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Themajority of HCC arises from viral hepatitis. Intra-cardiac involve-
ment rarely occurs in patients with HCC, and its frequency was found
around 2% in various series.7 A literature search for case reports was
performed on PubMed. We found 28 case reports or literature reviews
of HCC with cardiac involvement that were published in the literature.
Most of the cardiac metastases are direct and contiguous extensions of
the intrahepatic HCC via hepatic vein and inferior vena cava.8 Various
cardiac symptoms or ﬁndings such as dyspnea, lower extremity
edema, sudden death, or dilatation of the jugular veins are generally
seen in HCC patients with intra-cardiac involvement.1,7 Echocardiogra-
phy is widely available and provides a simple, noninvasive technique
for the initial evaluation of cardiac involvement of any tumor. Echocar-
diography images both the myocardium and the cardiac chambers and
can usually identify the presence of amass, its mobility and its function-
al effects. Both computed tomography (CT) and magnetic resonance
imaging (MRI) provide noninvasive, high-resolution images of the
heart and the liver, MRI generally is preferred. In addition to furnishingFig. 2. Chest computed tomography image. (a) Axial image showing amass in the liver and othe
that has been taken 3months before the diagnosis of the cardiac involvement with hepatocelludetailed anatomic images,MRI offers clues as to the type of tumor that is
present.9 However, CT scanning is still useful when MRI is not immedi-
ately available or is contraindicated.
The prognosis of HCC with intra-cardiac involvement is very poor,
with a median survival range of 1–4 months.10 The risk for cardiopul-
monary collapse is high in such patients. Possible cardiopulmonary
complications include heart failure, tricuspid stenosis or insufﬁciency,
ventricular outﬂow tract obstruction, sudden cardiac death, pulmonary
embolism, and pulmonary metastasis.8 Multidisciplinary treatments to
control the growth of HCC and cardiac surgery in young patients offer
patients with cardiac involvement a useful chance of cure. However,
such therapeuticmodalities may not be feasible, especially if the patient
has a poor general performance, metastatic disease, or underlying
hepatic dysfunction.10 A cardiac surgery for cardiac involvement of
HCC to remove the mass can have high mortality.
This case report showed that intrahepatic HCC can disseminate and
invade the heart in a short time. Even there are no curative treatments
for metastatic HCC, following these patients with echocardiography
periodically may give notice about cardiac involvement. We want to
emphasize the importance of monitoring the patient with HCC by
echocardiography with short time intervals not only for side effects of
chemotherapy, but also to detect heart involvement of HCC.Disclosures
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